Literature DB >> 35350265

Antimicrobial therapy in resource-limited settings with high antimicrobial resistance: a case-based approach.

Nitin Gupta1.   

Abstract

Choosing antimicrobial therapy in resource-limited settings is challenging because of the lack of advanced diagnostics and limited treatment options. Furthermore, since most international guidelines do not account for settings with high antimicrobial resistance, it is difficult for primary care physicians to choose the right antibiotic. This review, therefore, attempts to summarise the principles of antimicrobial therapy in such settings through six hypothetical case scenarios.
Copyright © 2022 InfezMed.

Entities:  

Keywords:  antibiotics; antimicrobial stewardship; multi-drug resistance

Year:  2022        PMID: 35350265      PMCID: PMC8929731          DOI: 10.53854/liim-3001-8

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  20 in total

Review 1.  Antimicrobial stewardship in immunocompromised hosts.

Authors:  Lilian M Abbo; Ella J Ariza-Heredia
Journal:  Infect Dis Clin North Am       Date:  2014-06       Impact factor: 5.982

Review 2.  Considerations of antibiotic therapy duration in community- and hospital-acquired bacterial infections.

Authors:  Silvano Esposito; Isabella Esposito; Sebastiano Leone
Journal:  J Antimicrob Chemother       Date:  2012-07-24       Impact factor: 5.790

3.  Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

Authors:  Andre C Kalil; Mark L Metersky; Michael Klompas; John Muscedere; Daniel A Sweeney; Lucy B Palmer; Lena M Napolitano; Naomi P O'Grady; John G Bartlett; Jordi Carratalà; Ali A El Solh; Santiago Ewig; Paul D Fey; Thomas M File; Marcos I Restrepo; Jason A Roberts; Grant W Waterer; Peggy Cruse; Shandra L Knight; Jan L Brozek
Journal:  Clin Infect Dis       Date:  2016-07-14       Impact factor: 9.079

Review 4.  Sepsis and septic shock: Guideline-based management.

Authors:  Siddharth Dugar; Chirag Choudhary; Abhijit Duggal
Journal:  Cleve Clin J Med       Date:  2020-01-02       Impact factor: 2.321

Review 5.  Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy.

Authors:  F Kate Gould; David W Denning; Tom S J Elliott; Juliet Foweraker; John D Perry; Bernard D Prendergast; Jonathan A T Sandoe; Michael J Spry; Richard W Watkin
Journal:  J Antimicrob Chemother       Date:  2011-11-14       Impact factor: 5.790

Review 6.  Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment.

Authors:  E-T Piperaki; L S Tzouvelekis; V Miriagou; G L Daikos
Journal:  Clin Microbiol Infect       Date:  2019-03-23       Impact factor: 8.067

7.  Comparison of Dual β-Lactam therapy to penicillin-aminoglycoside combination in treatment of Enterococcus faecalis infective endocarditis.

Authors:  Abdelghani El Rafei; Daniel C DeSimone; Aalap D Narichania; M Rizwan Sohail; Holenarasipur R Vikram; Zhuo Li; James M Steckelberg; Walter R Wilson; Larry M Baddour
Journal:  J Infect       Date:  2018-06-30       Impact factor: 6.072

8.  Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia.

Authors:  Mark J Siedner; Alicia Galar; Belisa B Guzmán-Suarez; David W Kubiak; Nour Baghdady; Mary Jane Ferraro; David C Hooper; Thomas F O'Brien; Francisco M Marty
Journal:  Clin Infect Dis       Date:  2014-03-18       Impact factor: 9.079

Review 9.  Principles of antimicrobial therapy.

Authors:  Jeffrey M Tessier; W Michael Scheld
Journal:  Handb Clin Neurol       Date:  2010-01-19

10.  Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.

Authors:  Thijs Ten Doesschate; Sander Kuiper; Cees van Nieuwkoop; Robert Jan Hassing; Tom Ketels; Suzan P van Mens; Wouter van den Bijllaardt; Akke K van der Bij; Suzanne E Geerlings; Ad Koster; Evert L Koldewijn; Judith Branger; Andy I M Hoepelman; Cornelis H van Werkhoven; Marc J M Bonten
Journal:  Clin Infect Dis       Date:  2022-08-25       Impact factor: 20.999

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.